News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
drugs pills and capsules

Experimental Gastric Cancer Drug Enters Early Trial

Athenex and Eli Lilly and Company are conducting a phase 1b clinical trial for advanced gastric cancer on the combination of Oraxol plus Cyramza (ramucircumab, the VEGF receptor 2 antagonist). Oraxol is an oral version of the common chemo drug paclitaxel.

Read Source
X